Avalon Trust’s Boston Scientific BSX Stock Holding History

Avalon Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6K	Hold	295	–	–	﹤0.01%	388
2026 Q1	$18.5K	Hold	295	–	–	﹤0.01%	375
2025 Q4	$28.1K	Sell	295 -24	-8%	-$2.35K	﹤0.01%	332
2025 Q3	$31.1K	Buy	319 +24	+8%	+$2.48K	﹤0.01%	363
2025 Q2	$31.7K	Hold	295	–	–	﹤0.01%	292
2025 Q1	$29.8K	Hold	295	–	–	﹤0.01%	312
2024 Q4	$26.4K	Hold	295	–	–	﹤0.01%	281
2024 Q3	$24.7K	Hold	295	–	–	﹤0.01%	256
2024 Q2	$22.7K	Hold	295	–	–	﹤0.01%	258
2024 Q1	$20.2K	Hold	295	–	–	﹤0.01%	270
2023 Q4	$17.1K	Hold	295	–	–	﹤0.01%	275
2023 Q3	$15.6K	Hold	295	–	–	﹤0.01%	243
2023 Q2	$16K	Hold	295	–	–	﹤0.01%	256
2023 Q1	$14.8K	Buy	+295	New	+$13.9K	﹤0.01%	247

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Avalon Trust's BSX Position: Q2 2026 in Review

Avalon Trust held its Boston Scientific (BSX) position steady in Q2 2026 at 295 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #388.

Avalon Trust first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $31.7K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Avalon Trust held 295 shares of Boston Scientific worth $12.6K as of Q2 2026.
Avalon Trust left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up ﹤0.01% of Avalon Trust's portfolio in Q2 2026, its #388 holding.
Avalon Trust first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
Avalon Trust's Boston Scientific position peaked at $31.7K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.